Insights Into Mondelez (MDLZ) Q4: Wall Street Projections for Key Metrics

Analysts on Wall Street project that Mondelez (MDLZ) will announce quarterly earnings of $0.67 per share in its forthcoming report, representing a decline of 20.2% year over year. Revenues are projected to reach $9.69 billion, increasing 4.1% from the same quarter last year.The current level reflects a downward revision of 2.7% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.Given this perspective, it's time to examine the average forecasts of specific Mondelez metrics that are routinely monitored and predicted by Wall Street analysts.The consensus among analysts is that 'Geographic Revenue- North America' will reach $2.85 billion. The estimate points to a change of +2.6% from the year-ago quarter.The combined assessment of analysts suggests that 'Geographic Revenue- Europe' will likely reach $3.80 billion. The estimate suggests a change of +7.4% year over year.The average prediction of analysts places 'Geographic Revenue- AMEA' at $1.84 billion. The estimate points to a change of +6.2% from the year-ago quarter.Based on the collective assessment of analysts, 'Geographic Revenue- Latin America' should arrive at $1.18 billion. The estimate indicates a change of -6.6% from the prior-year quarter.Analysts' assessment points toward 'Operating Income- AMEA- Non-GAAP' reaching $238.65 million. Compared to the present estimate, the company reported $246 million in the same quarter last year.Analysts forecast 'Operating Income- Europe- Non-GAAP' to reach $550.97 million. The estimate is in contrast to the year-ago figure of $643 million.According to the collective judgment of analysts, 'Operating Income- North America- Non-GAAP' should come in at $411.21 million. Compared to the present estimate, the company reported $505 million in the same quarter last year.The collective assessment of analysts points to an estimated 'Operating Income- Latin America- Non-GAAP' of $115.01 million. The estimate is in contrast to the year-ago figure of $159 million.View all Key Company Metrics for Mondelez here>>>Mondelez shares have witnessed a change of -1.8% in the past month, in contrast to the Zacks S&P 500 composite's +2.9% move. With a Zacks Rank #4 (Sell), MDLZ is expected underperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Mondelez International, Inc. (MDLZ): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks